Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 313546-18-8 | MDL No. : | MFCD09750473 |
Formula : | C8H8BNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RGCVYEOTYJCNOS-UHFFFAOYSA-N |
M.W : | 160.97 | Pubchem ID : | 16218401 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 45.95 |
TPSA : | 64.25 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.64 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.91 |
Log Po/w (WLOGP) : | -0.45 |
Log Po/w (MLOGP) : | -0.03 |
Log Po/w (SILICOS-IT) : | -0.32 |
Consensus Log Po/w : | 0.02 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.72 |
Solubility : | 3.1 mg/ml ; 0.0193 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.84 |
Solubility : | 2.3 mg/ml ; 0.0143 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.75 |
Solubility : | 2.86 mg/ml ; 0.0178 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.86 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; water; In tetrahydrofuran; at 20℃; for 0.25h; | Using a modification of the procedure by Hall and co-workers,refPreviewPlaceHolder8n-BuLi (1.6 M, 7.5 mL, 12.0 mmol) was added drop-wise to a solution of 4-bromo-3-methylbenzonitrile (2.34 g, 12.0 mmol) in anhydrous THF (24 mL) at -98 C. The mixture was stirred at -98 C for 10 min and trimethylborate (2.0 mL, 18 mmol) was added drop-wise. The reaction mixture was kept at -98 C for 30 min before being warmed to room temperature and stirred for a further 15 min. Aqueous HCl (1 M, 5 mL, 5 mmol) was added and the mixture was stirred for 15 min before being diluted with H2O (20 mL) and extracted with EtOAc (3×20 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo. Pinacol (1.42 g, 12.0 mmol) and MgSO4 (1.44 g, 12.0 mmol) were added to a solution of the residue dissolved in CH2Cl2 (25 mL). The mixture was stirred for 15 h at room temperature, MgSO4 removed by filtration and the filtrate concentrated in vacuo. The product was purified by column chromatography (5% EtOAc/petroleum ether) to give the boronic ester14 (2.59 g, 89%) as needles (petroleum ether); [Found: C, 69.44; H, 7.68, N, 5.61. C14H18NO2B requires C, 69.17; H, 7.46; N, 5.76%]; mp=139.5-140.5 C (petroleum ether); numax (neat): 2969, 2235, 1347, 1146, 1062 cm-1; deltaH (400 MHz, CDCl3) 7.83 (1H, d, J 8.0 Hz, ArH), 7.41-7.47 (2H, m, ArH), 2.56 (3H, s, Ar-Me), 1.36 (12H, s, 2× CMe2); deltaC (101 MHz, CDCl3) 145.6, 136.1, 132.6, 128.0, 119.0, 113.9, 84.1, 24.8, 21.9; deltaB (96 MHz, CDCl3): 30.7; m/z (EI): 243 (M+, 10), 228 (80), 84 (100); HRMS (EI): M+, found 243.1440. C14H18NO2B requires 243.1431. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In 2-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indol-6-yl]benzaldehyde, trifluoroacetic Acid Salt; | Example 23 4-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indol-6-yl]-3-methylbenzonitrile, Trifluoroacetic Acid Salt Using 2-methyl-4-cyanophenyl boronic acid and following the procedures in EXAMPLE 7, tert-butyl (7bR,11aS)-6-bromo-1,2,7b,10,11,11a-hexahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indole-9(8H)-carboxylate was converted into the title compound of EXAMPLE 23. 1H NMR (CDCl3): delta 8.70 (broad s, 2H), 7.55 (s, 1H), 7.51 (d, 1H, J=7.7 Hz), 7.26 (app d, 1H), 6.96 (s, 1H), 6.91 (s, 1H), 3.85 (ABq, 2H, JAB=15.7 Hz), 3.66-3.58 (m, 3H), 3.50-3.39 (m, 2H), 3.32-3.12 (m, 3H), 2.97-2.88 (m, 1H), 2.82-2.73 (m, 1H), 2.31 (s, 3H), 2.30-2.22 (m, 2H). LRMS (ES+) 362.4 (M+H)+. | |
In 2-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indol-6-yl]benzaldehyde, trifluoroacetic Acid Salt; | Example 23 4-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indol-6-yl]-3-methylbenzonitrile, trifluoroacetic acid salt Using 2-methyl-4-cyanophenyl boronic acid and following the procedures in EXAMPLE 7, tert-butyl (7bR,11aS)-6-bromo-1,2,7b,10,11,11a-hexahydro-4H-pyrido[4,3-b][1,4]thiazepino[6,5,4-hi]indole-9(8H)-carboxylate was converted into the title compound of EXAMPLE 23. 1H NMR (CDCl3): delta 8.70 (broad s, 2H), 7.55 (s, 1H), 7.51 (d, 1H, J=7.7 Hz), 7.26 (app d, 1H), 6.96 (s, 1H), 6.91 (s, 1H), 3.85 (ABq, 2H, JAB=15.7 Hz), 3.66-3.58 (m, 3H), 3.50-3.39 (m, 2H), 3.32-3.12 (m, 3H), 2.97-2.88 (m, 1H), 2.82-2.73 (m, 1H), 2.31 (s, 3H), 2.30-2.22 (m, 2H). LRMS (ES+): 362.4 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With Ba(OH)2;Pd(PPh3)4; | Step A Tert-butyl (8aS,12aR)-2-(4-cyano-2-methylphenyl)-4,5,6,7,8a,9,10,11,12,12a-decahydroazepino[3,2,1-hi]pyrido[4,3-b]indole-11(8aH)-carboxylate (0.095 g, 86%) was prepared by the general method of Example 319, step A from tert-butyl (8aS,12aR)-2-bromo-4,5,6,7,9,10,12,12a-octahydroazepino[3,2,1-hi]pyrido [4,3-b]indole-11(8aH)-carboxylate (0.10 g, 0.25 mmol), <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (0.080 g, 0.50 mmol), Pd(PPh3)4 (12 mg, 0.010 mmol), and Ba(OH)2 (0.17 M, 3.0 mL, 0.51 mmol) as a white foam. MS (ESI): 444 (base, M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With Ba(OH)2;Pd(PPh3)4; | Step A Tert-butyl (7aS,11aR)-2-(4-cyano-2-methylphenyl)-5,6,7a,8,9,10,11,11a-octahydro-4H-pyrido[3',4':4,5]pyrrolo[3,2,1-ij]quinoline-10(7aH)-carboxylate (0.073 g, 65%) was prepared by the general method of Example 319, step A from tert-butyl (7aS,11aR)-2-bromo-5,6,7a,8,9,10,11,11a-octahydro-4H-pyrido[3',4':4,5]pyrrolo[3,2,1-ij]quinoline-10(7aH)-carboxylate (0.10 g, 0.26 mmol), <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (0.088 g, 0.52 mmol), Pd(PPh3)4 (12 mg, 0.010 mmol), and Ba(OH)2 (0.17 M, 3.0 mL, 0.51 mmol) as a white foam. MS (ESI): 430 (base, M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,2-dimethoxyethane; water; for 12.0h;Heating / reflux; | Preparation of Intermediate (4'-Cvano-3,5-difluoro-2'-methyl-biphenyl-4-ylmethyl)-(3-methyl-butyl)- carbamic acid tert-butyl ester (1-1 d):4-Bromo-2,6-difluoro-benzyl)-(3-methyl-butyl)-carbamic acid tert-butyl ester (IUy. 10.0 g) was combined with <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (6.0 g), palladium tetrakis(triphenylphosphine) (2.2 g), 1,2-dimethoxy ethane (60 ml) and 2M aqueous sodium carbonate (5.0 ml) under a nitrogen atmosphere. After stirring vigorously while being heated at reflux for 12 hours, the reaction mixture was cooled to room temperature, diluted with water and extracted with ethyl acetate (2 times). The combined organic layers were washed with brine, dried over magnesium sulfate, filtered and concentrated under reduced pressure. The residue was purified by chromatography on silica eluting with ethyl acetate in heptane to provide the title compound (Md).1H NMR (CDCI3): delta 0.87 (d, 6H), 1.3-1.6 (m, 12 H), 2.28 (s, 3H), 3.1-3.3 (m, 2H), 4.5-4.7 (m, 2H), 6.81 (d, 2H), 7.27 (d, 1 H), 7.20 (d, 1H), 7.56 (s, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,2-dimethoxyethane; water; at 95℃; for 48.0h; | Preparation of Intermediate (^-Cvano-?^'-dimethyl-biphenyl-^ylmethvD-O-methvi-butvD-carbamic acid tert-butyl ester (l-2d):(4-bromo-3-methyl-benzyl)-(3-methyl-butyl)-carbamic acid tert-butyl ester (L2c: 12g) was combined with <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (7.2Og), palladium tetrakis(triphenylphosphine) (3.Og), 1 ,2-dimethoxy ethane (100 ml) and 2M aqueous sodium carbonate (50 ml_). After stirring vigorously while being heated at 950C for 48 hours, the reaction mixture was cooled to room temperature, diluted with water and extracted with ethyl acetate (2 times). The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by chromatography on silica eluting with 10% ethyl acetate in heptane to provide the title compound (l-2d).1H NMR (CDCI3): delta 0.87 (d, 6H), 1.3-1.6 (m, 12 H), 1.99 (s, 3H), 2.06 (s, 3H), 3.1-3.3 (m, 2H), 4.4 (m, 2H), 6.97 (d, 1H), 7.08-7.11 (m, 2H), 7.18 (d, 1 H), 7.50 (d, 1H), 7.55 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,2-dimethoxyethane; water; at 95℃; for 48.0h; | Preparation of Intermediate (3-Chloro-4'-cyano-2'-methyl-biphenyl-4-ylmethyl)-(3-methyl-butyl)-carbamic acid tert-butyl ester (l-3d):To a 250 ml round bottom flask was added (4-bromo-2-chloro-benzyl)-(3-methyl-butyl)-carbamic acid tert-butyl ester (K3c: 12g) followed by the <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (7.2Og), 1 ,2- dimethoxy ethane (100 ml_), 2M aqueous sodium carbonate (50 ml) and palladium tetrakis(triphenylphosphine) (3.Og). After heating the reaction mixture at 950C for 48 hours, the mixture was cooled to room temperature, diluted with water and extracted with ethyl acetate (2 times). The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to afford the title compound (l-3d).1H NMR (CDCI3): delta 0.89 (d, 6H), 1.3-1.6 (m, 12 H), 2.28 (s, 3H), 3.2-3.3 (m, 2H), 4.5-4.6 (m, 2H), 7.15 (d, 1 H), 7.28 (bs, 3H), 7.51 (d, 1H), 7.55 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With caesium carbonate;tetrakis(triphenylphosphine) palladium(0); In acetonitrile; at 20℃;Reflux; | Intermediate 173: Ethyl 1 -[4-(2-[(4'-cyano-2',3-dimethyl-4-biphenylyl)methyl]oxy}-3,5- difluorophenyl)-1 ,3-thiazol-2-yl]-4-piperidinecarboxylate; To a solution of ethyl 1-[4-(2-[(4-bromo-2-methylphenyl)methyl]oxy}-3,5-difluorophenyl)-1 ,3- thiazol-2-yl]-4-piperidinecarboxylate (Intermediate 135, 0.07 g, 0.127 mmol) and (4-cyano-2- methylphenyl)boronic acid (0.041 g, 0.254 mmol) in acetonitrile (20 ml) was added cesium carbonate (0.083 g, 0.254 mmol) and Palladium tetrakis (7.33 mg, 6.35 mumol). The reaction was then stirred to reflux during one night. TLC (Chex /EtOAc: 80/20) showed that the reaction was incomplete. <strong>[313546-18-8](4-cyano-2-methylphenyl)boronic acid</strong> (0.041 g, 0.254 mmol) and Palladium tetrakis (7.33 mg, 6.35 mumol) was added and the reaction was stirred to reflux during five hours and stirred at room temperature for 48 hours. The reaction was incomplete but treated. The crude reaction was filtered on celite and concentrated in vacuo. Purifcation by flash chromatography on silica was carried out using DCM/MeOH 99/1 gave the title compound (0.06 g, 0.102 mmol, 80 % yield) as an oil. LC/MS: m/z 588 [M+H]+, Rt 4.66 min. 1H NMR (CDCI3, 300 MHz) deltal.10) (d, 1 H), 7.59-7.52 (m, 3H), 7.35-7.28 (d, 3H), 7.16 (brs 1 H), 6.83 (m, 1 H), 5.05 (s, 2H), 4.19 (q, 2H), 4.04 (m, 2H), 3.17 (m, 2H), 2.57 (m, 1 H), 2.47 (s, 3H), 2.33 (s, 3H), 2.06 (m, 2H), 1.90 (m, 2H), 1.30 (t, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,2-dimethoxyethane; water; at 105℃; | Description 31 : Ethyl 1-(4-(5-methyl-2-(2-methyl-4-(4-cvano-2- methylphenyl)benzyloxy)-phenyl)pyrimidin-2-yl)-piperidine-4-carboxylate (D31); To a solution of ethyl 1-(4-( 5-methyl-2-(2-methyl-4-bromo-benzyloxy)-phenyl)pyrimidin-2-yl)- piperidine-4-carboxylate (D24, 0.4g, 0.763 mmol) in DME (50ml) and water (5ml) were added Pd(PPh3)4 (0.044 g, 0.038 mmol), <strong>[313546-18-8](4-cyano-2-methylphenyl)boronic acid</strong> (0.184 g, 1.144 mmol) and Na2CO3 (0.202 g, 1.907 mmol). The reaction was heated at 1050C overnight and then poured into water. After extraction with CH2CI2, the organic phase was dried (Na2SO4) and concentrated under reduced pressure. The residue was purified by chromatography on silicagel (CH2CI2 / MeOH, 99/1 ). The title compound was obtained as a colorless oil (0.37g, yield= 87%). LC/MS: 561.1 (M+H), Rt= 4.55min. 1H NMR (CDCI3, ppm): 8.27 (d, 1 H), 7.75 (s, 1 H), 7.58 (s, 1 H), 7.54 (d, 1 H), 7.49 (d, 1 H), 7.33 (d, 1 H), 7.24 (d, 1 H), 7.14 (m, 3H), 7.02 (d, 1 H), 5.14 (s, 2H), 4.79 (Id, 2H), 4.17 (q, 2H), 3.09 (t, 2H), 2.60 (m, 1 H), 2.4 (s, 3H), 2.38 (s, 3H), 2.32 (s, 3H), 2.02 (m, 2H), 1.76 (m, 2H), 1.28 (t, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium carbonate;dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; In water; N,N-dimethyl-formamide; at 90℃; for 15.0h;Sealed; | Step 1 3-Methyl-4-(2-oxo-2,3-dihydro-1H-indol-5-yl)-benzonitrile To a pressure flask was added; 5-bromoindolin-2-one (10.0 g, 47.2 mmol), <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (9.11 g, 56.6 mmol) were combined with DMF (370 ml) to give a light brown solution, a solution of sodium carbonate in water (37 ml) was added, while the mixture was degassed with nitrogen, a catalytic amount of Pd(dppf)Cl2*CH2Cl2 was added, and the flask sealed. The reaction mixture was heated to 90 C. for 15 h., water was added, the dark solid was collected, the solid was washed with water, MeOH and 20% EtOAc/hexanes to give 3-methyl-4-(2-oxo-2,3-dihydro-1H-indol-5-yl)-benzonitrile as a dark purple solid (12.1 g, 103%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61.6% | With potassium carbonate;dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; In 1,4-dioxane; water; at 100℃; for 4.0h;Inert atmosphere; | Step 1: 2-(2-Chloro-phenyl)-5-(4-cyano-2-methyl-phenyl)-indole-1-carboxylic acid ethyl ester A suspension of ethyl 2-(2-chlorophenyl)-5-iodo-1H-indole-1-carboxylate (100 mg, 235 mmol, Eq: 1.00), <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (49.2 mg, 305 mummol, Eq: 1.3), Potassium carbonate (97.4 mg, 705 mummol, Eq: 3) in Dioxane (3.00 ml) and Water (0.6 ml) was purged with nitrogen (10 min) and then 1,1'-bis(diphenylphosphino)ferrocenedichloro palladium(II) dichloromethane complex (19.2 mg, 23.5 mummol, Eq: 0.1) was added and r*n. mixture was heated at 100 C for 4 hr. Filtered through a pad of Celite, washed with DCM, solvent removed in vacuo, the residue redissolved in DCM, washed with water, brine, dried (Magnesium sulfate). Concentrated, chromatographed (silica gel, 10% EtOAc-Hexane) to obtain ethyl 2-(2-chlorophenyl)-5-(4-cyano-2-methylphenyl)-1H-indole-1-carboxylate (60 mg, 145 mummol, 61.6% yield) as a off-white powder. LC/MS: (M+H)=415. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; water; at 80℃; for 12.0h; | Example 57Synthesis of (E)-2'-(3-guanidino-2-methyl-3-oxo-propenyl)-2-methyl-biphenyl-4-carboxamidine<Step 1>Intermediate 1 (100 mg, 0.253 mmol) and 2-methyl-4-cyanophenyl boronic acid (61.0 mg. 0.379 mmol) were dissolved in a mixed solution of dioxane and water (v/v=3/1, 4.0 mL). Pd(PPh3)4 (14.6 mg, 13.0 mumol) and Na2CO3 (107 mg, 1.01 mmol) were added to the solution and then stirred at 80 C. for 12 hours. After cooling it to room temperature, the solvent was eliminated in vacuo and then purified by reversed phase HPLC (0.1% TFA in water/CH3CN) to obtain the objective intermediate (90 mg, 80%).MS: 319 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.59 g | With magnesium sulfate; In dichloromethane; at 20℃; for 15.0h;Inert atmosphere; | Using a modification of the procedure by Hall and co-workers,refPreviewPlaceHolder8n-BuLi (1.6 M, 7.5 mL, 12.0 mmol) was added drop-wise to a solution of 4-bromo-3-methylbenzonitrile (2.34 g, 12.0 mmol) in anhydrous THF (24 mL) at -98 C. The mixture was stirred at -98 C for 10 min and trimethylborate (2.0 mL, 18 mmol) was added drop-wise. The reaction mixture was kept at -98 C for 30 min before being warmed to room temperature and stirred for a further 15 min. Aqueous HCl (1 M, 5 mL, 5 mmol) was added and the mixture was stirred for 15 min before being diluted with H2O (20 mL) and extracted with EtOAc (3×20 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo. Pinacol (1.42 g, 12.0 mmol) and MgSO4 (1.44 g, 12.0 mmol) were added to a solution of the residue dissolved in CH2Cl2 (25 mL). The mixture was stirred for 15 h at room temperature, MgSO4 removed by filtration and the filtrate concentrated in vacuo. The product was purified by column chromatography (5% EtOAc/petroleum ether) to give the boronic ester14 (2.59 g, 89%) as needles (petroleum ether); [Found: C, 69.44; H, 7.68, N, 5.61. C14H18NO2B requires C, 69.17; H, 7.46; N, 5.76%]; mp=139.5-140.5 C (petroleum ether); numax (neat): 2969, 2235, 1347, 1146, 1062 cm-1; deltaH (400 MHz, CDCl3) 7.83 (1H, d, J 8.0 Hz, ArH), 7.41-7.47 (2H, m, ArH), 2.56 (3H, s, Ar-Me), 1.36 (12H, s, 2× CMe2); deltaC (101 MHz, CDCl3) 145.6, 136.1, 132.6, 128.0, 119.0, 113.9, 84.1, 24.8, 21.9; deltaB (96 MHz, CDCl3): 30.7; m/z (EI): 243 (M+, 10), 228 (80), 84 (100); HRMS (EI): M+, found 243.1440. C14H18NO2B requires 243.1431. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium carbonate;bis-triphenylphosphine-palladium(II) chloride; In 1,4-dioxane; water; at 80℃; for 0.333333h; | Step B: Preparation 1, 3 -bis( 1,1 -dimethylethyl) 2-(4'-cyano-5,2'-dimethyl[l,l'- biphenyl] -3 -yl)propanedioateA mixture of 1, 3 -bis( 1,1 -dimethylethyl) 2-(3-iodo-5-methylphenyl)propanedioate (the product of Step A, 320 mg, 0.74 mmol), <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (178 mg, 1.11 mmol), sodium carbonate (78 mg, 0.74 mmol), bis(triphenylphosphine)palladium(II) dichloride (52 mg, 0.074 mmol), dioxane (5 mL), and water (1 mL) was heated to 80 C and stirred for 20 minutes. The reaction mixture was then cooled to room temperature, and filtered through a plug of silica gel eluting with 20% ethyl acetate in hexanes. Concentration of the eluant under reduced pressure provided a brown oil (430 mg) containing the crude product, which was used in the next step without further purification..H NMR (CDCI3) delta 7.70-7.10 (m, 6H), 4.436 (s, 1H), 2.402 (s, 3H), 2.289 (s, 3H), 1.469 (s, 18H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | With sodium acetate; antimony(III) chloride; acetic acid;palladium diacetate; at 20℃; for 72.0h;Inert atmosphere; | Preparation 68 (+/-)-4-(4,4-Dimethyl-3-oxo-cyclohexyl)-3-methyl-benzonitrile 4-Cyano-2-methylphenylboronic acid (0.81 g, 5 mmol), 6,6-dimethylcyclohex-2-enone (Canadian Journal of Chemistry, 1981, 59, 2096-2115) (0.55 g, 5 mmol), SbCl3 (0.11 g, 0.5 mmol), sodium acetate (0.82 g, 10 mmol), and palladium acetate (0.11 g, 0.5 mmol) are added to acetic acid (30 mL) under an atmosphere of argon. The reaction mixture is stirred at room temperature for three days. The mixture is filtered and the filtrate is poured into water (150 mL). The organic phase is separated and the aqueous phase is extracted with ethyl acetate (3*100 mL). The combined organic layers are washed with saturated sodium bicarbonate solution (3*100 mL), brine (3*50 mL), dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue is purified by silica gel column chromatography eluting with pet ether: EtOAc=10:1 to give the title compound as a light yellow solid (0.6 g, 50%). GC/MS 241 (M+1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Preparation 57 1-Tetrahydropyran-2-yl-6,7-dihydro-5H-indazol-4-one and 2-Tetrahydropyran-2-yl-6,7-dihydro-5H-indazol-4-one 2,5,6,7-Tetrahydro-indazol-4-one (US2009/11180 A1) (5.0 g, 36.7 mmol) is added to a solution of dihydropyran (3.4 g, 40.4 mmol) in CH2Cl2 (100 mL) and the mixture is treated with p-toluensulfonic acid (0.1 g, 0.58 mmol) and stirred at room temperature for 3 days. Saturated NaHCO3 solution is added, and the contents are transferred to a separatory funnel. The organics are washed with brine, dried over Na2SO4, filtered and concentrated to dryness. The residue is purified by silica gel chromatography eluting with CH2Cl2 to give the title compounds (5.32 g, 66%) as a mixture of regioisomers. 1H NMR (300 MHz, CDCl3) delta 8.04 (s, 1H), 7.90 (s, 1H), 5.35-5.32 (m, 1H), 4.11-4.01 (m, 1H), 3.73-3.66 (m, 1H), 2.96-2.91 (m, 1H), 2.87-2.84 (m, 1H), 2.51-2.47 (m, 2H), 2.19-2.02 (m, 4H), 1.72-1.61 (m, 4H).Preparation 58 (1-Tetrahydropyran-2-yl-6,7-dihydroindazol-4-yl)trifluoromethanesulfonate and (2-Tetrahydropyran-2-yl-6,7-dihydroindazol-4-yl)trifluoromethanesulfonate 1-Tetrahydropyran-2-yl-6,7-dihydro-5H-indazol-4-one and 2-tetrahydropyran-2-yl-6,7-dihydro-5H-indazol-4-one (2.03 g, 9.22 mmol) are added to THF (100 mL), the solution is cooled to -78 C., and treated with LiHMDS (10.14 mL, 10.14 mmol). After stirring for 1 hour, a solution of N-phenylbis(trifluouromethanesulfonimide) (3.68 g, 10.14 mmol) in THF (20 mL) is added drop wise at -78 C., and allowed to warm to room temperature over 17 hours. The reaction is quenched with saturated NH4Cl, diluted with diethyl ether, and the organics are washed with 0.1 N HCl, brine, dried over Na2SO4, filtered, and concentrated to dryness. The residue is purified by silica gel chromatography eluting with 85:15 hexanes /ethyl acetate to give the title compounds (2.3 g, 51%) as a 3:1 mixture of regioisomers. ES/ MS m/z 352 (M+H), 269 (M-THP).Preparation 59 3-Methyl-4-(1-tetrahydropyran-2-yl-6,7-dihydroindazol-4-yl)benzonitrile or 3-Methyl-4-(2-tetrahydropyran-2-yl-6,7-dihydroindazol-4-yl)benzonitrile (1-Tetrahydropyran-2-yl-6,7-dihydroindazol-4-yl)trifluoromethanesulfonate, (2-tetrahydropyran-2-yl-6,7-dihydroindazol-4-yl)trifluoromethanesulfonate (1.0 g, 2.84 mmol) and <strong>[313546-18-8](4-cyano-2-methylphenyl)boronic acid</strong> (0.502 g, 3.12 mmol) are added to dioxane (80.0 mL) and Na2CO3 (0.601 mg, 5.68 mmol, 2.0 M) and de-gassed with a stream of nitrogen. The solution is treated with tetrakis(triphenylphosphine)palladium (0.33 g, 0.28 mmol) and heated to 80 C. under nitrogen for 17 hours. The mixture is cooled to ambient temperature and filtered through a plug of diatomaceous earth. The filtrate is diluted with ethyl acetate and the layers are separated. The organics are washed with saturated NaHCO3, brine, dried over Na2SO4, filtered, and concentrated to dryness. The residue is purified by silica gel chromatography eluting with 9:1 hexanes /ethyl acetate to 4:1 hexanes /ethyl acetate to give one of the title compounds (0.492 g, 55%) as a single regioisomer. ES/ MS m/z 320 (M+H), 236 (M-THP). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69.4% | With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In ethanol; water; toluene; at 80℃; for 5.0h;Inert atmosphere; | To a mixture of 3-bromo-4-(4-methoxyphenyl)thiophene (Scheme I, 2, X1 = 4-methoxyphenyl) (1.7 g, 6.316 mmol), <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (Scheme I, 2A, X2 = 4-cyano-2- methylphenyl) (1.535 g, 6.316 mmol), sodium carbonate (1.34 g, 12.63 mmol), toluene (60 mL) in a mixture of ethanol (36 mL) and water (24 mL) under nitrogen was added Pd(PPh3)4 (0.7 g, 0.606 mmol). The mixture was stirred at 80C for 5 h, poured into water (50 mL), and extracted with ethyl acetate (50 mLx3). The organic extracts were dried over anhydrous magnesium sulfate (6 g), evaporated, and purified by column chromatography on silica gel (petroleum ether/ethyl acetate =50: 1) to give 4-(4-(4-methoxyphenyl)thiophen-3-yl)-3-methylbenzonitrile (Scheme I, 3, Xi = 4-methoxyphenyl, X2 = 4-cyano-2-methylphenyl) (1.34 g, yield 69.4%). XH NMR (DMSO-J6400MHz): delta 7.68-7.65 (m, 3H), 7.58 (d, J = 3.2 Hz, 1H), 7.33 (d, J = 8.0 Hz, 1H), 6.98 (d, J = 8.8 Hz, 2H), 6.80 (d, J = 8.8 Hz, 2H), 3.70 (s, 3H), 1.79 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65.42% | With nickel(II) iodide; sodium hexamethyldisilazane; (1S,2S)-2-hydroxycyclohexylamine hydrochloride; In isopropyl alcohol; at 90℃; for 2.0h;Inert atmosphere; | (4-Cyano-2-methyl-phenyl)boronic acid (1.75 g, 10.87 mmol), diiodonickel (102 mg, 0.326 mmol), (1S,2S)-2-aminocyclohexan-1-ol hydrochloride (50 mg, 0.33 mmol) and NaHMDS (2.01 g, 11.0 mmol) were combined in isopropanol (10 mL) under N2 in a pressure vial. A solution of 3-iodooxetane (1.00 g, 5.44 mmol) in isopropanol (1 mL) was added. The vial was immersed in a pre-heated 90 C. oil bath and stirred for 2 h, then cooled, diluted with ethanol (20 mL), filtered over Celite, concentrated, then absorbed onto Celite and purified by silica gel column chromatography (0-60% EtOAc/hexane) to give 3-methyl-4-(oxetan-3-yl)benzonitrile (616 mg, 3.556 mmol, 65.42%) as a white solid. ESI-MS m/z calc. 173.1. found 174.3 (M+1)+; Retention time: 1.09 minutes (3 min run). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77.7% | With palladium diacetate; sodium carbonate; DavePhos; In methanol; toluene; at 100℃; for 2.5h;Inert atmosphere; | To 2-iodo-pentarnethyi BODIPY (800 mg. 2.06 mmoi) dissolved in 60 mL oftoluene:methanoi (5:1) under argon atmosphere was added Na2CO3 (874 mg, 24 mmol),Pd(OAc)2 (46.2 mg, 020 mrnoi), 2-methyh4-cyanophenyiboronicacid (994.8 mg, 6.2 nunol) and2-c1icyciohexyiphosphino2 ?/Ac1Vdimethy1amino)biphenyl (121 .6 mg, 03 1 mrnofl. The mxtnre was heated to 100C and stirred. After 2.5 hours, thin layer chromatography showed thedisappearance of 2iodopentamethyI BODIPY and the reaction was diluted with 100 mL of water, The aqueous phase was extracted th ree times with toluene (300 mE). The combinedorganic extracts were dried with MgSO4 and concentrated using a rotary evaporator. The crude mixture was purified using flash, column chromatography (toluene) to give 6 (606.3 tug, 1. .6mmol, 77.7%) as a red solid.?H NMR (400 MHz, C.D2C12) oe 7,34 (5, IH). 7.57 (d. J 7.6 Hz, IH), 7.25 (d. J ? 7.6 Hz, IH),6.17 (s, lED, 2.67 (s, 3H), 2.52 (s, 3H), 2.4 (s, 3H), 2.28 (s, 3H), 2.19 (s, 3H), 2.18 (s, 3H); ?3CNMR (100 MHz, CD2,C12) oe 154.9, 150.2, 142.5, 142.4, 139.6, 138.9, 137.1, 133.5, 132.6, 131.9, 131.6, 130.8, 129.4, 121.8, 118.9, 111.5, 19.4, 17.2, 16.7, 15.0, 14.2, 12.7. ESIMS [M-i-H]+calcd for C22H23BF2N3 378.20, found 378.27. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | With potassium phosphate; tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; isopropyl alcohol; at 140℃; for 3.0h;Microwave irradiation; Inert atmosphere; | General procedure: In a MW vial were successively added K3PO4 (531 mg, 2.5 mmol, 2.5 equiv), 5 (233 mg, 1.0 mmol, 1 equiv), the appropriately substituted o-tolylboronic acid (1.2 mmol, 1.2 equiv), Pd(PPh3)4 (58 mg, 5 mol %) and a mixture of 1,4-dioxane-i-PrOH (9:1, 5 mL). The MW vial was purged with N2 for 5 min then heated at 140 C for 3 h under MW conditions. The resulting mixture was filtered through a pad of Celite and the pad was washed several times with EtOAc. The filtrate was concentrated in vacuo. The crude material was purified by column chromatography on silica gel (EtOAc-n-heptane, 1:3) to give the desired product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; sodium carbonate; In 1,4-dioxane; water; at 110℃; for 1.0h;Inert atmosphere; Microwave irradiation; | Combined 6-(4-bromo-5-methoxy-lH-pyrazol-l-yl)-N-((tetrahydro-2H-pyran-4- yl)methyl)nicotinamide (25 mg, 0.063 mmol), <strong>[313546-18-8](4-cyano-2-methylphenyl)boronic acid</strong> (30.5 mg, 0.190 mmol), sodium carbonate (26.6 mg, 0.316 mmol), and PdCl2(dppf)-CH2Cl2 adduct (2.58 mg, 3.16 muiotaetaomicron) in dioxane (0.2 mL) and water (0.05 mL) and purged with nitrogen. The reaction mixture was heated in a microwave on high absorbance for 1 hour at 110C, cooled to 23C and diluted with water (1 mL) to give a residue. The residuewas extracted with EtOAc (2 x 1 mL), the organic layers were combined, washed with brine (0.5 mL), dried over Na2S04, filtered through a Hydrophilic PTFE 0.45 urn filter (Millipore Millex-LCR), rinsed with EtOAc, and dried in vacuo to provide 6-(4-(4-cyano-2-methylphenyl)-5-methoxy- lH-pyrazol-l-yl)-N-((tetrahydro-2H-pyran-4-yl)methyl)nicotinamide (27.3 mg, 100 % yield) as a brown oil. MS m/z [M+H]+ 432.5. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With palladium diacetate; sodium carbonate; XPhos; In propan-1-ol; at 100℃; for 2.0h;Inert atmosphere; Microwave irradiation; | A solution of intermediate N (100 mg, 0.21 mmol), 10-1 (34 mg, 0.21mmol) and aqueous Na2CO3 (2M, 0.5 mL, 1 mmol) in 1-propanol (2 mL) is bubbled with Ar for 5 min. Then Xphos (10 mg, 0.02 mmol) and catalyst palladium acetate (5mg, 0.02 mmol) are added under Ar. The vial is sealed and heated to 100 C for 2 h in microwave reactor. The reaction is cooled and diluted with MeOH (5 mL), filtered and concentrated. The crude is purified by reverse phase prep HPLC eluting with 10-100 % CH3CN in water (+0.1% TFA). The concentrated solid was basified by PL-HC03 MP column to yield title compound 10. MS (ES+): m/z 515.4 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,4-dioxane; at 140℃; for 0.333333h;Microwave irradiation; | The solution of (S)-tert-butyl 7-(((trifluoromethyl)sulfonyl)oxy)-3 ,4,8,8atetrahydropynolo[I ,2-a ]pyrazine-2( lH)-carbox ylate (227 mg, 0.61 0 mmol), <strong>[313546-18-8]2-methyl-4-cyanophenylboronic acid</strong> (118 mg, 0.732 mmol), Tetrakis(triphenylphosphine)palladium (70.410 mg, 0.061 mmol) and IN Na2C03 solution (1 829 ~tl, 1.829 mmol) in dioxane (4 mL) was heatedat 140C at microwave for 20 min. After removing the volatile, the residue was purified onBiotage using EtOAc/hexane as eluting solvents to give over 10-1 OCV to give (S)-tert-butyl 7-( 4-cyano-2-methyl phenyl)-3,4,8,8a-tetrahydropyrrolo[J ,2-a ]pyrazine-2(1 H)-carboxylate.LC/MS:[M+lt= 340. 1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
40 mg | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate; In tetrahydrofuran; for 0.333333h;Reflux; | General procedure: 80 mg of the aryl bromide prepared in Example 316 together with 32 mg of (5-chloropyridin-2-yl)boronic acid was first placed in 1 ml tetrahydrofuran, treated with 17.3 mg of 1,1'-bis(diphenylphosphino)ferrocenodichloropalladium(II) and 0.17 ml of 1M potassium carbonate solution and heated in the microwave for 10 minutes at 120 C. (100 watts). After fresh addition of 11 mg of (5-chloropyridin-2-yl)boronic acid and 17.3 mg of the palladium(II) catalyst, the reaction mixture was again heated in the microwave for 10 minutes at 120 C. (100 watts) until complete conversion. The reaction mixture was concentrated. After HPLC purification, this yielded 15 mg of the title compound. Analogously to Example 317, 40 mg of the title compound was obtained from 80 mg of 54 and 38 mg of <strong>[313546-18-8](2-methyl-4-cyanophenyl)boronic acid</strong> under reflux. 1H-NMR (400 MHz, DMSO-d6): delta [ppm], 1.20-1.34 (2H), 1.36-1.69 (2H), 2.28 (4H), 2.53 (3H), 2.69-3.19 (2H), 3.28 (3H), 3.36-3.43 (2H), 3.43-3.50 (2H), 3.54-3.77 (1H), 4.37 (3H), 7.18 (1H), 7.37-7.50 (6H), 7.74 (1H), 7.83 (1H), 8.15 (1H), 8.52 (1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium carbonate; In water; N,N-dimethyl-formamide; at 120℃; for 2.08333h;Inert atmosphere; | 0.33 ml (0.67 mmol) of a 2M sodium carbonate solution in water was added to a solution of 140 mg (0.22 mmol) of 4-bromo-N-alpha-[(trans-4-[(tert-butoxycarbonyl)amino]methyl}cyclohexyl)carbonyl]-N-[4-(2H-tetrazol-5-yl)phenyl]-L-phenylalaninamide and 53.9 mg (0.33 mmol) of <strong>[313546-18-8](4-cyano-2-methylphenyl)boronic acid</strong> in 2.5 ml DMF, and the mixture was degassed with argon for 5 min. 16.3 mg (0.022 mmol) of 1,1?-bis(diphenylphosphino)ferrocenepalladium(II)chloride were added and the mixture was stirred at 120 C. in a preheated oil bath for 2 h. The mixture was filtered through kieselguhr and washed through with ethyl acetate. The filtrate was diluted with ethyl acetate and water and acidified with 10% strength citric acid solution, and the phases were separated. The organic phase was dried over magnesium sulphate and concentrated under reduced pressure. The residue was stirred with ethyl acetate, and the solid was filtered off and dried under high vacuum. This gave 45 mg (20% of theory, 67% pure) of the title compound. LC-MS (Method 1): Rt=1.11 min; MS (ESIpos): m/z=663 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium carbonate; In 1,4-dioxane; water; at 100℃; for 2.0h;Inert atmosphere; | Step l : A suspension of tert-butyl (5-chloro-[1,2,4]triazolo[1,5-a]pyridin-7-yl)carbamate (Intermediate 17, 0.2 g, 0.744 mmol), <strong>[313546-18-8](4-cyano-2-methylphenyl)boronic acid</strong> (CAS 126747-14-6,120 mg, 0.744 mmol), PdCl2(dppf) (54.5 mg, 0.074 mmol) and Na2C03 (0.158 g, 1.489 mmol) in dioxane (2 mL) and water (0.4 mL) was flushed with N2 and heated to 100 C for 2 h. The reaction was cooled to rt and partitioned between EtOAc and water. The organic phase was collected, washed with brine, dried (phase separator) and concentrated in vacuo. The resulting residue was purified by flash chromatography (0- 100% EtOAc in petrol on basic silica) to afford tert-butyl (5-(4-cyano-2-methylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-7-yl)carbamate. 1H NMR (400 MHz, DMSO-< delta ppm 1.52 (s, 9 H), 2.10 (s, 3 H), 7.15 - 7.23 (m, 1 H), 7.61 - 7.74 (m, 1 H), 7.82 - 7.90 (m, 1 H), 7.92 - 8.02 (m, 2 H), 8.31 (s, 1 H), 10.10 (s, 1 H) MS ES+: 294 (M-'Bu) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium phosphate; In 1,4-dioxane; water; at 90℃; for 2.0h;Inert atmosphere; Sealed tube; | General procedure: "Procedure 2 A mixture of an aryl halide (0.505 mmol), a boronic acid (0.757 mmol), potassium phosphate (0.536 g, 2.52 mmol) and PdCl2(dppf) (0.037 g, 0.050 mmol) in dioxane (4 mL) and water (1 mL) was purged with nitrogen. The reaction mixture was heated in a microwave reactor at 120 C for 45 min. The reaction mixture was concentrated in vacuo and the crude product was purified by reverse phase preparative HPLC eluting with acetonitrile / water (with 0.1% ammonia) to afford the title compound. For example, the compound of Example 8 (3-methyl-4-[1,2,4]triazolo[1,5-a]pyridin-5-yl]benzonitrile) was prepared according to Procedure 2 as follows: PdCl2(dppf) (5.53 g, 7.574 mmol) was added to a degassed suspension of 5-bromo-[1,2,4]triazolo[1,5-a]pyridine (CAS 143329-58-2, 30 g, 151.4 mmol), <strong>[313546-18-8](4-cyano-2-methylphenyl)boronic acid</strong> (CAS 313546-18-8), 26.82 g, 166 mmol) and potassium phosphate (96.35 g, 454.4mmol) in 1,4-dioxane (24 mL) and water (6.00 mL) under nitrogen. The reaction was degassed, sealed and then heated to 90 C for 2 h. The reaction mixture was diluted with water and extracted with EtOAc. The organic layer was washed with brine, dried over Na2S04, filtered and solvent removed in vacuum to give title crude compound. The crude compound was purified by flash chromatography (0-50 % EtOAc in hexane on Si02). The resulting reisude was dissolved in minimal hot (70 C) ethanol allowed to cool to room temperature with stirring. The crystals were filtered and dried under vacuum to afford the title compound.1H NMR (400 MHz, DMSO-< delta ppm 2.09 (s, 3 H) 7.22 - 7.30 (m, 1 H) 7.62 - 7.71 (m, 1 H) 7.76 - 7.89 (m, 2 H) 7.91 - 8.02 (m, 2 H) 8.49 (s, 1 H)" |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; sodium carbonate; In 1,4-dioxane; at 50℃; for 2.0h;Inert atmosphere; | Step 1: A suspension of 5,7-dichloro-[1,2,4]triazolo[1,5-a]pyrimidine (CAS 78706-26-0) (1 g, 5.29 mmol), <strong>[313546-18-8](4-cyano-2-methylphenyl)boronic acid</strong> (CAS 313546-18-8, 0.852 g, 5.29 mmol), Na2C03 (0.589 g, 5.56 mmol) and PdCl2(dppf)-CH2Cl2Adduct (0.432 g, 0.529 mmol) in dioxane (30 mL) and water (6 mL) was flushed with N2 and heated to 50 C for 2 h. The reaction was poured into EtOAc and washed with water. The organic was collected, dried (phase separator) and concentrated in vacuo to afford crude 4-(5-chloro-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-3-methylbenzonitrile which was taken directly onto the next step. MS ES+: 270.2 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | In toluene; at 120℃; for 1.0h;Molecular sieve; | A mixture of <strong>[313546-18-8]4-cyano-2-methylphenylboronic acid</strong> (906 mg, 5.6 mmol), 2,2-dimetyl-1,3-propanediol (641 mg, 6.15 mmol) and 3 molecular sieves (1 g) in anhydrous toluene (10 mL) was heated at 120 C. for 1 h and then was allowed to cool to room temperature. The mixture was filtered and the filtrate was concentrated in vacuo. The residue was purified by flash chromatography (SiO2, eluted with gradient from 20% to 60% EtOAc in hexanes). Yield: 1.054 g (82%) as yellowish solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,4-dioxane; water; at 90℃; for 3.0h;Inert atmosphere; | A mixture of (±)-trans-N-(6-bromo-8-chloro-3-isoquinolyl)-2-cyano-cyclopropanecarboxamide (350 mg, 1.0 mmol), <strong>[313546-18-8]2-methyl-4-cyanophenylboronic acid</strong> (193 mg, 1.2 mmol), Pd(PPh3)4 (115 mg, 0.1 mmol) and Na2CO3 (212 mg, 2 mmol) in 1,4-dioxane (15 mL) and water (1 mL) under Ar was stirred at 90 C. for 3 hours. The mixture was concentrated and purified by column chromatography (ethyl acetate/hexane=1:3) to afford (±)-trans-N-[8-chloro-6-(4-cyano-2-methyl-phenyl)-3-isoquinolyl]-2-cyano-cyclopropanecarboxamide (380 mg, 86% yield) as a white solid. LCMS (ESI) [M+H]+=387.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
31.5% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium carbonate; In ethanol; water; toluene; at 85℃; for 16.0h; | Step 4 methyl 4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl)-3-(4'-cyano-2'-me thyl-[1,1'-biphenyl]-4-yl)propanamido)benzoate 17f Compound 17d (180 mg, 0.28 mmol), <strong>[313546-18-8](4-cyano-2-methylphenyl)boronic acid</strong> 17e (90.84 mg, 0.56 mmol, prepared by a known method disclosed in ""), [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium (II) (20.65 mg, 0.03 mmol) and sodium carbonate (89.73 mg, 0.85 mmol) were added to a mixed solvent of toluene (8 mL), ethanol (3 mL) and water (1 mL). After completion of the addition, the reaction solution was warmed up to 85C, and stirred for 16 hours. After cooling to room temperature, the reaction solution was added with 15 mL of water, and extracted with ethyl acetate (20 mL*2). The organic phases were combined, washed with saturated sodium chloride solution (20 mL*2), dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography with elution system A to obtain the title compound 17f (200 mg, yield: 31.5%). MS m/z (ESI): 674.5 [M+1] |
Tags: 313546-18-8 synthesis path| 313546-18-8 SDS| 313546-18-8 COA| 313546-18-8 purity| 313546-18-8 application| 313546-18-8 NMR| 313546-18-8 COA| 313546-18-8 structure
[ 1328882-30-9 ]
(2-Cyano-4-methylphenyl)boronic acid
Similarity: 0.98
[ 313546-19-9 ]
3-Cyano-2-methylphenylboronic acid
Similarity: 0.90
[ 1328882-30-9 ]
(2-Cyano-4-methylphenyl)boronic acid
Similarity: 0.98
[ 313546-19-9 ]
3-Cyano-2-methylphenylboronic acid
Similarity: 0.90
[ 1328882-30-9 ]
(2-Cyano-4-methylphenyl)boronic acid
Similarity: 0.98
[ 313546-19-9 ]
3-Cyano-2-methylphenylboronic acid
Similarity: 0.90
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :